Portal de investigación
A Study to Evaluate Seroprevalence of Antibodies to AAV8 and Assessment of Biomarkers in Patients with Late-Onset Pompe Disease.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
AUDENTES THERAPEUTICS, INC., DOING BUSINESS AS ASTELLAS GENE THERAPIES, AN ASTELLAS COMPANY
Cita
A Study to Evaluate Seroprevalence of Antibodies to AAV8 and Assessment of Biomarkers in Patients with Late-Onset Pompe Disease. (AT845-02). AUDENTES THERAPEUTICS, INC., DOING BUSINESS AS ASTELLAS GENE THERAPIES, AN ASTELLAS COMPANY. 2024IP:NURIA MUELAS GÓMEZ.